Immunohisto Chemistry Advancements Offer More Accurate in Mesothelioma Diagnosis
Saturday, May 16th, 2009Malignant mesothelioma is a unusual and aggressive tumor for which no successful therapy has been discovered despite the breakthrough of many potential molecular and genetic targets. The late stage of Malignant pleural mesothelioma diagnosis and the long latency that exists between exposures and diagnosis have made it tricky to completely evaluate what risk factors do […]